MARC record from Internet Archive

LEADER: 03992cam 22006614a 4500
001 ocm60825579
003 OCoLC
005 20200526191831.0
008 050628s2006 nyua b 001 0 eng
010 $a 2005051284
040 $aDNLM/DLC$beng$cDLC$dYDX$dNLM$dBAKER$dUKM$dIXA$dMUQ$dBTCTA$dYDXCP$dIG#$dI8H$dBDX$dOCLCF$dOCLCO$dOCLCQ$dMMV$dUKMGB
015 $aGBA617685$2bnb
016 7 $a101251610$2DNLM
016 7 $a013387231$2Uk
019 $a1022714938$a1080794666
020 $a0393704610
020 $a9780393704617
035 $a(OCoLC)60825579$z(OCoLC)1022714938$z(OCoLC)1080794666
042 $apcc
050 00 $aRJ504.7$b.C66 2006
060 00 $a2006 C-088
060 10 $aQV 77.2$bC752 2006
082 00 $a615/.78/083$222
100 1 $aConnor, Daniel F.
245 10 $aPediatric psychopharmacology :$bfast facts /$cDaniel F. Connor, Bruce M. Meltzer.
250 $a1st ed.
260 $aNew York :$bW.W. Norton & Co.,$c©2006.
300 $axxvi, 685 pages :$billustrations ;$c25 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
500 $a"A Norton professional book."
504 $aIncludes bibliographical references (pages 615-669) and index.
520 1 $a"Pediatric Psychopharmacology provides empirically-based, state-of-the-art knowledge as well as clear practical guidance regarding assessment, prescription, monitoring, and discontinuation of medications.
520 8 $aA critical resource for all health care professionals working with children and adolescents."--Jacket.
505 00 $g1.$tIntroduction to pediatric psychopharmacology --$g2.$tBasic pharmacology --$g3.$tGeneral principles of treatment --$g4.$tStimulants --$g5.$tAntidepressants --$g6.$tMood stabilizers --$g7.$tAntipsychotics --$g8.$tDrugs to treat extrapyramidal symptoms and syndromes --$g9.$tAnxiolytics --$g10.$tAdrenergic agents --$g11.$tOther medications --$g12.$tHerbal and alternative medicines --$g13.$tElectroconvulsive therapy in adolescents --$g14.$tAttention-deficit/hyperactivity disorder --$g15.$tdisorders and Tourette's disorder --$g16.$tConduct disorder, oppositional defiant disorder, and impulsive aggression --$g17.$tMood disorders --$g18.$tPsychotic disorders --$g19.$tExtrapyramidal syndromes and central serotonin syndrome --$g20.$tAnxiety disorders --$g21.$tObsessive-compulsive disorder --$g22.$tPosttraumatic stress disorder --$g23.$tMental retardation, autism, and other pervasive developmental disorders --$g24.$tEating disorders --$g25.$tSleep disorders --$g26.$tOther important topics in pediatric psychopharmacology --$gApp. 1.$tPediatric psychopharmacology summary table : evidene of efficacy by drug and disorder in children and adolescents < 18 years old --$gApp. 2.$tPharmacodynamics of psychiatric medications commonly used in children and adolescents --$gApp. 3.$tPediatric psychopharmacology and the cardiovascular system --$gApp. 4.$tPractical tools for the clinical child and adolescent psychopharmacologist.
650 0 $aPediatric psychopharmacology.
650 12 $aPsychotropic Drugs$xtherapeutic use.
650 22 $aAdolescent.
650 22 $aAffective Symptoms$xdrug therapy.
650 22 $aChild.
650 22 $aChild Behavior Disorders$xdrug therapy.
650 22 $aPsychopharmacology$xmethods.
650 6 $aPsychopharmacologie pédiatrique.
650 7 $aPediatric psychopharmacology.$2fast$0(OCoLC)fst01056475
700 1 $aMeltzer, Bruce M.
938 $aBaker & Taylor$bBKTY$c65.00$d.00$i0393704610$n0006457801$sactive
938 $aBrodart$bBROD$n03499324$c$65.00
938 $aBaker and Taylor$bBTCP$n2005051284
938 $aIngram$bINGR$n9780393704617
938 $aYBP Library Services$bYANK$n2226592
029 1 $aAU@$b000027747219
029 1 $aIG#$b9780393704617
029 1 $aNLM$b101251610
029 1 $aYDXCP$b2226592
029 1 $aUKMGB$b013387231
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 116 OTHER HOLDINGS